- Home
- CCEP vs RGC Comparison
CCEP vs RGC Comparison
Compare CCEP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEP
- RGC
- Stock Information
- Founded
- CCEP 1986
- RGC 2014
- Country
- CCEP United Kingdom
- RGC Hong Kong
- Employees
- CCEP N/A
- RGC N/A
- Industry
- CCEP Beverages (Production/Distribution)
- RGC Medicinal Chemicals and Botanical Products
- Sector
- CCEP Consumer Staples
- RGC Health Care
- Exchange
- CCEP Nasdaq
- RGC Nasdaq
- Market Cap
- CCEP 42.7B
- RGC 38.6B
- IPO Year
- CCEP 1987
- RGC 2021
- Fundamental
- Price
- CCEP $94.76
- RGC $13.97
- Analyst Decision
- CCEP Buy
- RGC
- Analyst Count
- CCEP 6
- RGC 0
- Target Price
- CCEP $94.00
- RGC N/A
- AVG Volume (30 Days)
- CCEP 1.8M
- RGC 644.3K
- Earning Date
- CCEP 08-06-2025
- RGC 06-30-2025
- Dividend Yield
- CCEP 2.36%
- RGC N/A
- EPS Growth
- CCEP N/A
- RGC N/A
- EPS
- CCEP 3.91
- RGC N/A
- Revenue
- CCEP $24,468,658,468.00
- RGC N/A
- Revenue This Year
- CCEP $5.92
- RGC N/A
- Revenue Next Year
- CCEP $3.52
- RGC N/A
- P/E Ratio
- CCEP $23.93
- RGC N/A
- Revenue Growth
- CCEP 9.04
- RGC N/A
- 52 Week Low
- CCEP $72.38
- RGC $0.09
- 52 Week High
- CCEP $100.67
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- CCEP 46.46
- RGC 46.62
- Support Level
- CCEP $88.79
- RGC $12.60
- Resistance Level
- CCEP $98.78
- RGC $14.26
- Average True Range (ATR)
- CCEP 1.71
- RGC 1.25
- MACD
- CCEP -0.77
- RGC 0.18
- Stochastic Oscillator
- CCEP 50.25
- RGC 23.60
About CCEP Coca-Cola Europacific Partners plc
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia.In 2024, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume. Coke's largest bottler, Coca-Cola Femsa, sold over 4 billion unit cases (12%), and the third-largest, Coca-Cola HBC, serving Eastern Europe and North Africa, sold 2.8 billion unit cases (8%).TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.